WITHDRAWN: Mechanisms and potential therapeutic targets for intracerebral hemorrhage
Hemorrhagic Stroke · 2019
DOI: 10.1016/j.hest.2019.05.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hemorrhagic Stroke, 2019. Verfasst von Wei Hua und 6 weiteren Autor:innen. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In this review, we summarize recent research related to intracerebral hemorrhage (ICH) and offer new insight into its pathomechanisms. These underlying pathomechanisms of ICH provide clues for development of novel drugs or drug target screening. Specifically, recent research has provided evidence that iron chelators, lipid peroxidation/ferroptosis inhibitors, antagonists or agonists of prostaglandin E2 receptors (EP1/3 or EP2), and nonsteroidal anti-inflammatory drugs protect against ICH-induced brain edema and secondary brain tissue damage, and inhibit the toxicity of related tissue damage products. This review will provide a theoretical basis for testing new compounds that may have potential for future clinical trials.
Zitieren
APA
Hua, W., Yang, X., Chen, X., Ren, H., Hong, M., Wu, H., & Wang, J. (2019). WITHDRAWN: Mechanisms and potential therapeutic targets for intracerebral hemorrhage. Hemorrhagic Stroke. https://doi.org/10.1016/j.hest.2019.05.001
Vancouver
Hua W, Yang X, Chen X, Ren H, Hong M, Wu H, et al. WITHDRAWN: Mechanisms and potential therapeutic targets for intracerebral hemorrhage. Hemorrhagic Stroke. 2019. doi:10.1016/j.hest.2019.05.001
BibTeX
@article{Hua2019,
author = {Hua, Wei and Yang, Xiuli and Chen, Xuemei and Ren, Honglei and Hong, Michael and Wu, He and Wang, Jian},
title = {WITHDRAWN: Mechanisms and potential therapeutic targets for intracerebral hemorrhage},
journal = {Hemorrhagic Stroke},
year = {2019},
doi = {10.1016/j.hest.2019.05.001}
}
EUVIMED